جست‌وجوی استاد و پژوهشگر

Forest M. Whiteمشاهده پروفایل

استاد

• Metastasis
• Precision Medicine
• Immunology & Immunotherapy
• +۷ مورد دیگر

Professor Forest M. White is a faculty member at MIT's Department of Biological Engineering , where he holds the Ned C. and Janet Bemis Rice Professorship . He is affiliated with the Koch Institute for Integrative Cancer Research and the MIT Center for Precision Cancer Medicine . His research focuses on systems biology and computational modeling of signaling networks in cancer, particularly at the tumor-immune interface . Education: B.S. in Chemistry (Framingham State College, 1993), Ph.D. in Analytical Chemistry (Florida State University, 1997) Professional Journey: Postdoc at University of Virginia, Research Scientist at MDS Proteomics, Assistant Professor at MIT (2003), Mitsui Career Development Professor (2005-2008) White employs high-resolution mass spectrometry to analyze protein phosphorylation and antigen presentation in cancer models, complementing genomic/transcriptomic approaches. His lab has identified chronic stress response enzymes linking high-fat diets to metabolic dysfunction and discovered resistance mechanisms in cancer therapies through phosphoproteomics . Scientific Awards: Mitsui Career Development Professorship (2005-2008) Ruth and Joel Spira Award for Excellence in Teaching (2010) Fellowship from the Ludwig Center at MIT The White Lab actively recruits trainees (undergraduates, graduates, postdocs) through programs like MSRP , CSB , and HST . His work is supported by grants from Break Through Cancer and Ludwig Center , with collaborations spanning Cima Lab , Swanson Biotechnology Center , and MIT Koch Institute .

Michelle Doasمشاهده پروفایل

دانشیار

• Medical-surgical nursing
• Cardio-thoracic nursing
• Nursing in Long Term Care settings
• +۳ مورد دیگر

Michelle Doas is an Associate Professor of Nursing at Chatham University 's College of Health Sciences , where she has been actively contributing since 2007. Her expertise spans clinical nursing, education, and interdisciplinary research applications. Ed,D., MSN, BSN, RN Research Interests Dr. Doas focuses on critical thinking development in nursing education , adult literacy in healthcare , and reminiscence therapy . Her work bridges clinical practice with pedagogical innovation, exploring how techniques from service industries (e.g., Disney's hospitality model) can enhance patient satisfaction and communication in healthcare settings. Article Trends Her publications and presentations demonstrate a consistent emphasis on improving clinical outcomes through structured interventions like mind mapping for education, relaxation therapy for post-operative care, and concept mapping for knowledge organization. Key themes include patient safety , workplace culture , and interdisciplinary applications in nursing. Scientific Awards She is a member of the prestigious Sigma Theta Tau International Honor Society , recognizing her contributions to nursing scholarship. Additional Contributions Dr. Doas has served on the Business Faculty Search Committee (2008) and presented on diverse topics such as food handling safety in environmental science contexts and nursing career advocacy at high school outreach events.

Daniel Catchpooleمشاهده پروفایل

استاد

• Childhood Cancer Research
• Genomics
• Biomedical Data Science
• +۶ مورد دیگر

Professor Daniel Catchpoole serves as Deputy Head of School (Research) at the School of Computer Science, University of Technology Sydney (UTS), holding dual appointments at UTS and The Children's Hospital at Westmead. With over 20 years of research experience, he bridges computational sciences and pediatric cancer research through the Biomedical Data Science Lab in the Australian Artificial Intelligence Institute. His work integrates data analytics, artificial intelligence, and software development with molecular cancer biology to transform pediatric cancer treatment pathways. PhD in Cancer Cell Biology, University of New South Wales (1991-1995) Founding Fellow, Royal College of Pathologists Australasia (2010-present) Head, Children's Hospital at Westmead Tumour Bank (2001-present) Professor Catchpoole's research focuses on translational applications of genomics in childhood cancers, particularly acute lymphoblastic leukemia and neuroblastoma. His work combines high-throughput genomic technologies with advanced computational analysis to develop systems biology approaches for cancer patient assessment. Recent projects explore virtual reality applications for complex genomic data visualization and copper chelation therapies to enhance neuroblastoma immunotherapy. His research has received significant funding from Cancer Institute NSW, Sony Foundation, ARC, and NHMRC. His publication record spans biomedical data science, cancer genomics, and virtual reality applications in oncology. Recent work demonstrates leadership in 3D latent diffusion models for tumor segmentation, biobank economics, and innovative immunotherapies. His research consistently addresses the critical need for actionable knowledge from complex multidimensional biomedical data. Editorial Board Member, Cancers (2023) Associate Editor, Innovations in Digital Health, Diagnostics and Biomarkers (2019) Founding member and first President, Australasian Biospecimens Network Association Professor Catchpoole has supervised 17 Honours students (including 6 First Class Honours), 3 MSc students, and 12 PhD candidates across multiple institutions, with 6 current PhD students. His collaborative research bridges UTS's Faculty of Engineering and IT with The Children's Cancer Research Unit at The Children's Hospital at Westmead. Significant research funding includes Cancer Institute NSW grants, Sony Foundation VR projects, and ARC Discovery Projects focused on genomic data analysis and clinical decision support systems. His leadership extends to building frameworks for translational research, managing biobanks and clinical data linkages, and navigating governance requirements for cancer research. The Tumour Bank at Kids Research, CCRU, represents his long-standing commitment to pediatric cancer infrastructure development.

George E. Vatesمشاهده پروفایل

استاد

• Neurosurgery
• Pituitary Tumors
• Neuroendocrinology
• +۳ مورد دیگر

George E. Vates, MD, PhD, is a Professor in the Department of Neurosurgery and the Department of Medicine (Endocrine/Metabolism) at the University of Rochester Medical Center. He serves as neurosurgeon co-director of the University of Rochester Multidisciplinary Neuroendocrinology Clinic and is a key member of the University of Rochester Medical Faculty Group (URMFG), which comprises over 900 providers across 19 departments. Dr. Vates specializes in pituitary tumor surgery, cerebrovascular disorders, and skull base procedures, having performed over 120 transsphenoidal pituitary surgeries. Dr. Vates completed his academic training with exceptional distinction: Duke University: Bachelor's degree, summa cum laude (1988, Phi Beta Kappa) Rockefeller University: PhD in Neuroscience Weill Medical College of Cornell University: MD (1997, Alpha Omega Alpha) University of California, San Francisco: Neurosurgery Residency (1998-2003) Brigham and Women's Hospital, Harvard Medical School: Cerebrovascular/Skull Base Fellowship (2003-2004) His research focuses on pituitary tumor biology, neuroendocrinology, and surgical innovation. He established the Multidisciplinary Neuroendocrinology Clinic as a regional referral center for complex pituitary cases, integrating neurosurgical and endocrinological expertise. Current work emphasizes neuroprotective mechanisms in pituitary adenomas, surgical simulation technology, and optimizing outcomes for elderly glioma patients. Analysis of his 15 most recent publications reveals evolving research trajectories: contemporary studies (2019-2022) concentrate on pituitary tumor management, surgical simulation, and neurosurgical education, while earlier work (2002-2009) explored cerebrovascular anomalies, neural pathway mapping, and vascular malformations. Persistent themes include surgical technique refinement, tumor biology, and clinician training. Dr. Vates' scientific contributions have been recognized through: Phi Beta Kappa (1988) and Alpha Omega Alpha (1991) academic honors Neurosurgery Research and Education Foundation Fellowship (2006) Anspach Award for Cerebral Ischemia Research (2007) AANS Leadership Scholarship and Cone Pevehouse Award (2009) Ongoing service as St. Michael's Hospital Animal Care Committee reviewer As an educator, he mentors neurosurgery residents through clinical supervision and curriculum development, notably publishing on palliative care communication training. His research initiatives, including the 3D-printed cervical laminectomy simulator, demonstrate commitment to advancing surgical education. Current grants focus on neuroprotective strategies in pituitary tumors and resident training methodologies. Dr. Vates co-directs the Multidisciplinary Neuroendocrinology Clinic with endocrinologist Dr. Calvi, fostering collaboration between neurosurgery, endocrinology, and oncology. His clinical team manages complex pituitary cases across Rochester and Hornell campuses, while his research group develops surgical innovations and investigates tumor microenvironment interactions to improve patient outcomes.

Jacob Youngمشاهده پروفایل

استادیار

• Neuro-oncology
• Glioblastoma
• Brain Tumor Immunology
• +۶ مورد دیگر

Jacob Young, MD, is an Assistant Professor in the Department of Neurological Surgery at the University of California, San Francisco (UCSF) School of Medicine and a Principal Investigator in the UCSF Brain Tumor Center. His clinical practice focuses on neurosurgical management of adult brain tumors including gliomas, metastatic tumors, and meningiomas, utilizing advanced brain mapping techniques to preserve critical motor, language, and sensory functions during resection. Dr. Young's educational background includes a BS in Neuroscience from Duke University (2012), an MD from the University of Chicago Pritzker School of Medicine where he was elected to Alpha Omega Alpha Honor Medical Society (2017), and a neurosurgery residency at UCSF (2017-2024). His research program integrates laboratory investigations with clinical trials to address fundamental challenges in brain tumor treatment. His primary research interests center on understanding glioblastoma immune microenvironment dynamics and developing innovative therapeutic strategies. Key focus areas include: First-in-human clinical trials of novel immunotherapies Focused ultrasound-mediated blood-brain barrier disruption to enhance drug delivery Longitudinal molecular profiling of tumor evolution during treatment AI-driven tools for patient care navigation and clinical trial assessment Prospective outcomes research through the RANO resect group and NeuroPoint Alliance His work bridges fundamental tumor biology with translational applications to overcome treatment resistance. Analysis of Dr. Young's 15 most recent publications (2023-2025) reveals a strong emphasis on surgical innovation, tumor immunology, and molecular characterization. Key trends include: development of prognostic classification systems for resection extent, investigation of glioma-neuronal circuit interactions driving immunosuppression, and optimization of drug delivery strategies. His collaborative work within the RANO consortium establishes evidence-based surgical guidelines while his lab's focus on microenvironmental factors informs next-generation immunotherapies. Dr. Young has received significant recognition including: Chan-Zuckerberg Physician Scientist Fellowship (2021-2022) ASCO Young Investigator Award (2022-2023) Andrew J. Lockhart Focused Ultrasound Fellowship (2023) Multiple Harold Rosegay Teaching Awards from UCSF Howard Naffziger Award for Clinical Excellence His research is supported by NIH, NCI, Focused Ultrasound Foundation, and AANS grants. As lab director, Dr. Young mentors a diverse team including PhD candidates like Edward Valenzuela (DSCB program) and specialists in immunology and neuro-oncology. His lab participates in the RANO resect group, ENCRAM research program, and NeuroPoint Alliance to advance clinical protocols. Current projects include developing intraoperative focused ultrasound prototypes, single-cell analysis of tumor evolution, and AI tools for patient navigation through care pathways. Future work focuses on translating microenvironment discoveries into combination therapies targeting treatment resistance mechanisms.

• high resolution MRI
• visual perception
• functional imaging
• +۶ مورد دیگر

Reza Farivar-Mohseni is an Associate Professor at McGill University , affiliated with the Faculty of Medicine and Health Sciences and the Department of Ophthalmology and Visual Sciences . He serves as a Scientist at the RI-MUHC (Montreal General Hospital site), contributing to the Brain Repair and Integrative Neuroscience (BRaIN) Program and the Centre for Translational Biology . Research Interests: Dr. Farivar-Mohseni’s work focuses on cortico-cortical communication, information processing in the brain, and disruptions in neurological disorders like traumatic brain injury. He specializes in advancing non-invasive brain imaging (MRI) for both fundamental and clinical applications, particularly improving concussion detection and diagnosis. Publications: His research spans high-resolution MRI, visual perception, and functional imaging. Key themes include depth-cue invariance in object recognition, gamma-band neural representations, and cortical deficits in amblyopia. Recent studies (2025–2022) address computational neuroscience, vision screening tools, and neural imaging techniques. Labs & Collaborations: He collaborates with the MGH-MRI Research Platform and works within the Centre for Translational Biology , focusing on translating imaging advancements into clinical tools.

• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Medicine
• Asthma
• +۴ مورد دیگر

Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.

Marlene Behrmannمشاهده پروفایل

استاد

• Cognitive Neuroscience
• Cognitive Science
• Visual Perception
• +۴ مورد دیگر

Marlene Behrmann is the Thomas S. Baker University Professor of Psychology and Cognitive Neuroscience at Carnegie Mellon University (CMU), affiliated with the Dietrich College of Humanities and Social Sciences. She leads the Behrmann Lab, which moved to the University of Pittsburgh in 2023. Her research focuses on visual cognition, object recognition, and neural mechanisms of perception, with a particular emphasis on face and word recognition. Behrmann holds a B.A. and M.A. in Speech and Hearing Therapy and a Ph.D. in Psychology from the University of Toronto. She is a leader in her field, recognized by her induction into the National Academy of Sciences (2015) and the American Academy of Arts and Sciences (2019). Her work combines neuropsychological studies of patients with brain damage, neuroimaging, and computational modeling to explore visual processing. Recent research highlights include studies on dorsal-ventral pathway interactions, functional reorganization post-hemispherectomy, and autism-related sensory processing differences. Behrmann has advised numerous graduate students and postdocs, contributing to their academic and professional development. Key awards include her National Academy of Sciences membership and American Academy of Arts and Sciences fellowship. Her lab collaborates widely, publishing in top journals like Cerebral Cortex , PNAS , and Trends in Cognitive Sciences . She also engages in translational research to improve interventions for perceptual and cognitive disorders.

Andrew D. Eatonمشاهده پروفایل

استادیار

• Social Work
• Health Disparities
• HIV/AIDS Research
• +۸ مورد دیگر

Dr. Andrew D. Eaton is an Assistant Professor at the University of Regina’s Faculty of Social Work (Saskatoon Campus) and holds a Status-Only Assistant Professorship at the Factor-Inwentash Faculty of Social Work, University of Toronto. He earned his PhD and MSW from the University of Toronto and his BSW from Toronto Metropolitan University. His research focuses on HIV/AIDS, mental health crises, aging populations, sexual health, and harm reduction, with a commitment to community-based participatory research. Eaton’s work addresses complex comorbidities affecting marginalized groups, particularly sexual and gender minorities. He leads projects such as the '3 Infections, 1 Fight Study' using geospatial tools to reduce harm from injection drug use, and the 'ReportNeedles.ca' initiative to map needle disposal hotspots. His studies also explore cognitive remediation therapies for aging HIV-positive populations and crisis mental health response models. He holds grants from CIHR, SSHRC, CTN, and OHTN. His publications emphasize innovative interventions, including cognitive training programs, civilian-led crisis response systems, and global comparative studies on sexual identities. Eaton’s lab (eaton-lab.com) fosters collaboration between academics, practitioners, and communities to translate research into actionable health policies and practices.

Xin Luمشاهده پروفایل

دانشیار

• Cancer Biology
• Tumor Microenvironment
• Tumor Immunology and Immunotherapy
• +۱۲ مورد دیگر

Xin Lu is the John M. and Mary Jo Boler Collegiate Associate Professor in the Department of Biological Sciences at the University of Notre Dame. She is a full member of the Harper Cancer Research Institute (HCRI), the Boler-Parseghian Center for Rare and Neglected Diseases (CRND), and the Tumor Microenvironment and Metastasis Program at the Indiana University Simon Comprehensive Cancer Center. Her research spans tumor immunology, immunotherapy, metastasis, and multi-omics, with a focus on prostate, breast, and rare cancers. Ph.D. in Molecular Biology, Princeton University (2004–2010) B.S. in Biological Sciences, Tsinghua University, China (2000–2004) Postdoctoral Fellow, Dana-Farber Cancer Institute and M.D. Anderson Cancer Center (2010–2016) Assistant to Associate Professor, University of Notre Dame (2017–Present) Dr. Lu's research investigates the molecular and cellular mechanisms of tumor-immune crosstalk, particularly the role of myeloid-derived suppressor cells (MDSCs) and neutrophils in promoting immunotherapy resistance. Her lab uses genetically engineered mouse models, functional genomics, single-cell and spatial transcriptomics, and high-throughput screening to uncover novel therapeutic targets. A major focus is on how cancer-cell-intrinsic oncogenic signaling shapes the immunosuppressive tumor microenvironment. Her recent publications reveal mechanisms such as Acod1-mediated ferroptosis resistance in neutrophils, Pygo2-driven immunosuppression in prostate cancer, and the efficacy of ketogenic diets in overcoming checkpoint blockade resistance. These studies span multiple disciplines including cancer biology, immunology, metabolism, epigenetics, and bioengineering, reflecting a highly integrative approach to immuno-oncology. Jane Coffin Childs Postdoctoral Fellow John M. and Mary Jo Boler Faculty Appointment Cluster Chair, Cellular & Molecular Biology, IBMS PhD Program Junior Chair, Boler-Parseghian Center for Rare and Neglected Diseases Dr. Lu mentors a diverse team of graduate students, postdoctoral fellows, and undergraduates. Her lab is actively recruiting and has secured funding from federal agencies and private foundations. She collaborates with chemists, bioengineers, and bioinformaticians to develop novel therapeutics, including antibody-drug conjugates, CAR-NK cells, and small-molecule inhibitors. Her lab also develops innovative platforms like mini-tumor chips for immunotherapy evaluation. Her lab maintains affiliations with multiple interdisciplinary centers including the Warren Family Center for Drug Discovery, Eck Institute for Global Health, and Berthiaume Institute for Precision Health, underscoring her collaborative and translational research vision.

• Radiation Biophysics
• Cancer Radiotherapy
• Ionizing Radiation Effects
• +۴ مورد دیگر

David J. Brenner serves as Higgins Professor of Radiation Biophysics in Radiation Oncology and Environmental Health Sciences at Columbia University Medical Center. He directs both the century-old Center for Radiological Research and the Radiological Research Accelerator Facility (RARAF), leading interdisciplinary teams focused on radiation applications in medicine and safety. BA in Physics from Oxford University (1974) MSc in Radiation Physics from University of London (1976) MA in Physics Philosophy from Oxford University (1979) PhD in Physics from University of Surrey (1980) His research spans dual aspects of radiation: therapeutic applications in cancer treatment and risk assessment across diverse scenarios. Key initiatives include advancing carbon-ion therapy for pancreatic cancer, developing safe far-UVC light for pathogen elimination, and investigating low-dose radiation risks from medical imaging to nuclear terrorism. His team leverages RARAF's unique capabilities for mechanistic studies of radiation effects. Publications reveal dominant themes in radiation biophysics, with significant contributions to biodosimetry (RABiT platform), UV disinfection technology, and cancer risk modeling. Recent work emphasizes translational applications including medical countermeasures for radiation exposure and precision radiation oncology techniques. National Academy of Sciences Nuclear and Radiation Studies Board member National Council on Radiation Protection and Measurements member Radiation Research Society Failla Gold Medal recipient (2011) Oxford University Weldon Prize for mathematical biology (2015) Robert D. Moseley Award for Radiation Protection in Medicine Brenner leads multiple NIH-funded projects including biodosimetry development and UV disinfection research. His mentorship extends through directing Columbia's Radiological Research Accelerator Facility and training programs in radiological sciences. Current lab efforts focus on carbon-ion therapy mechanisms and 222-nm UV applications against drug-resistant pathogens, with active collaborations across oncology, microbiology, and physics disciplines.

Mario A. Svirskyمشاهده پروفایل

استاد

• Auditory Neuroscience
• Cochlear Implants
• Speech Perception
• +۳ مورد دیگر

Mario A. Svirsky is the Noel L. Cohen Professor of Hearing Science and Professor of Neuroscience at NYU Grossman School of Medicine. He leads the Laboratory for Translational Auditory Research, focusing on auditory neural prostheses like cochlear implants and their impact on speech perception and neuroplasticity. His work bridges clinical care and scientific discovery, addressing how the brain adapts to sensory deprivation and degraded auditory input. Education: PhD in Biomedical Engineering from Tulane University (1988). Postdoctoral training at MIT and prior academic appointments at Indiana University and Purdue University before joining NYU in 2005. Research: Explores cochlear implant performance optimization, speech perception in hearing-impaired individuals, and neuroplasticity mechanisms. Collaborates with the Froemke Lab on animal models of cochlear implantation. Active in developing computational models and signal processing techniques to improve implant efficacy. Funding: Principal investigator on multiple NIH grants (e.g., R01 DC016839, R01 DC016834) and industry partnerships. His lab’s work has advanced clinical management strategies for cochlear implant users, including those with contralateral hearing aids. Labs/Teams: Directs the Laboratory for Translational Auditory Research, collaborating with multidisciplinary teams including engineers, neuroscientists, and clinical audiologists. Mentors postdocs, audiologists, and medical students in auditory research.

Stefano CAMPOSTRINIمشاهده پروفایل

استاد

• Social Statistics
• Public Health
• Healthcare Systems
• +۶ مورد دیگر

Stefano CAMPOSTRINI is a Full Professor in the Department of Economics at Ca' Foscari University of Venice, specializing in Social Statistics (STAT-03/B). He serves as a Member of the technical-scientific Committee of the Ca' Foscari Challenge School and the Department of Economics' Committee. His research activities are supported by affiliations with the Research Institute for Social Innovation and the Research Institute for Innovation Management. Professor CAMPOSTRINI's research spans the intersection of statistical methodology, public health, and social policy. His work demonstrates expertise in advanced statistical techniques including Bayesian modeling, spatial analysis, and complex survey methodology. His primary focus areas include healthcare systems analysis, social innovation, public administration, and the economic aspects of health policy. He frequently addresses issues related to comorbidity patterns, healthcare service accessibility, and the application of artificial intelligence in healthcare settings. His publication record from 2021-2025 reveals significant trends in healthcare innovation, with particular emphasis on virtual hospital systems, AI applications in medicine, sustainable healthcare practices, and the statistical analysis of social services like early childhood education. His methodological contributions include novel approaches to analyzing regional health disparities and developing web-based tools for disease prevalence estimation. His research often employs expert consensus methods like Delphi techniques to address complex healthcare organizational challenges. Professor CAMPOSTRINI maintains active involvement in research initiatives through the Research Institute for Social Innovation and the Research Institute for Innovation Management. His work bridges advanced statistical methodology with practical applications in healthcare policy and social service delivery, making significant contributions to evidence-based decision making in public health and social policy domains across Italy and European contexts.

Mathew Yarossiمشاهده پروفایل

استادیار

• Movement Neuroscience
• Motor Physiology
• Clinical Research
• +۵ مورد دیگر

Mathew Yarossi is an Assistant Professor at Northeastern University with a joint appointment in the College of Engineering (Electrical and Computer Engineering) and Bouvé College of Health Sciences (Physical Therapy, Movement, and Rehabilitation Sciences). He holds a PhD from Rutgers University (2017) and joined Northeastern in 2022. Research Focus: His work bridges movement neuroscience, clinical research, and engineering, with emphasis on AI-driven solutions for rehabilitation. Key areas include physiological signal processing, neuromuscular control, and human-robot interaction. His NSF-funded project on dyadic object handover with robots highlights his interdisciplinary approach. Publications: Recent work explores VR-based interventions, EMG-driven prosthetics, and computational modeling of transcranial stimulation. His 2025 patent on virtual reality experiment design underscores his translational impact. Awards: Holds a patent for VR experiment systems (2025). Advising & Grants: Mentors students in PEAK Experiences programs and collaborates with the U.S. Army on AI applications in combat systems. His lab is part of the Institute for Experiential AI.

Annette Byrneمشاهده پروفایل

استاد

• Precision Medicine
• Molecular Imaging
• Angiogenesis
• +۷ مورد دیگر

Professor Annette Byrne is a leading academic at RCSI University of Medicine and Health Sciences , where she serves as Professor of Physiology and Head of the Precision Cancer Medicine (PCM) Group. She has held this position since 2019 after progressing through roles as Lecturer (2008), Senior Lecturer (2013), and Associate Professor (2017). Her research focuses on precision medicine approaches for colorectal and brain cancers , integrating multi-modality molecular imaging , Next Generation Sequencing , and patient-derived xenograft models . PhD in Cell Biology (University of York, 1999) John Kerner Fellowship in Gynaecologic Oncology (UCSF, 1999-2001) Scientist at Pharmacyclics Inc. (2001-2003) Senior Scientist at Angion Biomedica Corp. (2003-2005) Principal Investigator at UCD Conway Institute (2005-2008) Her research interest lies in precision cancer medicine , particularly elucidating predictive biomarkers (genomic, transcriptomic, proteomic) and identifying novel therapeutic targets . Key methodologies include radiomics , fluorescence-guided surgery , and systems modeling of apoptosis pathways. She has pioneered Ireland's first Tumour Xenograft Facility and Translational In Vivo Imaging Centre . Recent publications highlight her work on cross-species radiomics , cell-free DNA analysis , and glioblastoma microenvironment subtyping . Her Marie Curie networks (Gliotrain, Glioresolve) and COLOSSUS project have trained 25+ PhD researchers in brain cancer therapeutics. Over €45M in national/international grants Member of Royal Irish Academy (2025) Highly cited in Cancer Discovery , Annals of Oncology , and Nature journals She supervises multiple PhD candidates and leads the RCSI Precision Cancer Medicine Group , which utilizes computational approaches and molecular imaging to improve cancer treatment outcomes. Her GLIORESOLVE and EDIReX projects focus on tumor microenvironment manipulation and distributed PDX infrastructure.